Google
SEPN — SEPTERNA, INC. COMMON STOCK (Healthcare >> Biotechnology)
SEPN FAQ
What is SEPN's P/E ratio?
SEPTERNA, INC. COMMON STOCK (SEPN) currently trades at a P/E ratio of 168.49.
What is SEPN's ROE?
SEPTERNA, INC. COMMON STOCK reports a Return on Equity (ROE) of -9.52%.
What is SEPN's dividend yield?
SEPTERNA, INC. COMMON STOCK offers a dividend yield of 0.00%.
What is SEPN's Deepscope Quality Score?
Deepscope rates SEPN's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy SEPN?
Deepscope's AI Timing Score for SEPN is 87 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does SEPN belong to?
SEPTERNA, INC. COMMON STOCK is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 31.15
Price
-0.22
(-0.70%)
Day Change
|
|
|---|
SEPN, ファンダメンタルスコアはnot good ( ファンダメンタル = 31) but テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
P/Eが高い。割高銘柄。
ROEが低い
ROAが低い
ROEの伸びが低い
平均ROEが低い
ROAがROEに比べて低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
39% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 91 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 31.15 |
| PBV / Sector |
3.64 / 4.63
|
| Earning Per Share | -0.82 |
| PE / Sector |
168.49 / 17.43
|
| PEG or PE/Growth / Sector |
-0.44 / 0.53
|
| Average 1M Daily Value |
8.97 M
|
| Average 1W Daily Value |
10.39 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
41% |
| ポイントになる統計 |
|
52% |
| 配当 |
|
8% |
| 登録情報 |
| Analyze Date | 2026-06-06 09:09:30 |
| Symbol | SEPN |
| Name | SEPTERNA, INC. COMMON STOCK |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 45.08 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 1,377.06 / 8,857.28 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 250 East Grand Avenue, South San Francisco, CA, United States, 94080
Phone: 650 338 3533
Website: https://septerna.com
Employees: 130
Sector: Healthcare >> Biotechnology
Description: Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. It develops PTH1R Program, oral small molecule Parathyroid Hormone 1 Receptor agonists for the treatment of hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 negative allosteric modulator (NAM) for chronic spontaneous urticaria and other mast cell diseases; and TSHR Program, an oral small molecule TSHR NAM for graves' disease and thyroid eye disease. In addition, it focuses on other therapeutic areas, including neurology, women's health, cardiovascular disease, and respiratory disease. It has global collaboration and license agreement with Novo Nordisk to discover, develop and commercialize multiple potential oral small molecule therapies for metabolic-related diseases based on certain specified molecular targets. The company was formerly known as GPCR NewCo, Inc. and changed its name to Septerna Inc. in June 2021. Septerna, Inc. was incorporated in 2019 and is headquartered in South San Francisco, California.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
